Adaptive Laboratory Evolution under gradual ciprofloxacin stress leads to efflux-mediated ciprofloxacin resistance and an increase in endogenous antibiotic production in Streptomyces coelicolor
Abstract
Abstract Streptomyces are soil-dwelling bacteria harboring a vast reservoir of transcriptionally silent antibiotic-resistant genes. Mobilization of these resistance genes to pathogens results in the dissemination of multidrug resistance when exposed to differential antibiotic pressure. To determine the evolution of resistance, we employed adaptive laboratory evolution (ALE) in Streptomyces coelicolor under gradually increasing concentrations of ciprofloxacin, starting at the minimum inhibitory concentration (MIC) to 4X MIC. The evolved strain CipRr exhibited elevated resistance towards ciprofloxacin with cross-resistance to other fluoroquinolones, such as ofloxacin and moxifloxacin, and collateral sensitivity to the protein synthesis inhibitors chloramphenicol and tetracycline. Compared to the WT cells, CipRr showed elevated production of secondary metabolites actinorhodin and undecylprodigiosin, altered morphology, and reduced ROS production. Whole Genome Sequencing revealed mutations in transcriptional regulators and other metabolic genes, leading to enhanced activity of efflux pumps that conferred high-level ciprofloxacin resistance. Overall, this study demonstrates that evolutionary strategies in antibiotic producers such as streptomyces can help uncover the genetic determinants linked to antibiotic resistance, secondary metabolism, and morphological differentiation.
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.